Received Feb 27, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z008873 | — |
No additional AE; Customer called to report TE. Vaccines were administered to patients. Symptoms were not reported. Permission to contact was granted. AE was filled in case #s 02952625; 02952646; 02952673; 02952674; 02952675; 02952676; 02952677; 02952678; 02952679; 02; This spontaneous report was received from a Medical Assistant and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (lot #Z008873 has been verified to be valid, expiration date not provided but upon internal review was determined to be 14-MAY-2027) (dose, frequency, routed of administration was not reported) indicated as prophylaxis. The vaccine was reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT), (route, dose, dose number, lot # and expiration date were not reported) On 11-FEB-2026, the vaccine administered underwent a temperature excursion (Product storage error) at a temperature of -14C up to -10 C for a time frame of 2 hours 5 minutes and 0 seconds. No additional adverse events were reported.
MERCK STERILE DILUENT